0001193125-17-170690.txt : 20170515 0001193125-17-170690.hdr.sgml : 20170515 20170515162717 ACCESSION NUMBER: 0001193125-17-170690 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20170515 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20170515 DATE AS OF CHANGE: 20170515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: METLIFE INC CENTRAL INDEX KEY: 0001099219 STANDARD INDUSTRIAL CLASSIFICATION: LIFE INSURANCE [6311] IRS NUMBER: 134075851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-15787 FILM NUMBER: 17844679 BUSINESS ADDRESS: STREET 1: 1095 AVENUE OF AMERICAS CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 212-578-5500 MAIL ADDRESS: STREET 1: 1095 AVENUE OF AMERICAS CITY: NEW YORK STATE: NY ZIP: 10036 8-K 1 d369445d8k.htm 8-K 8-K
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): May 15, 2017

 

 

METLIFE, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Delaware   1-15787   13-4075851
(State or Other Jurisdiction
of Incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

200 Park Avenue, New York,

New York

  10166-0188
(Address of Principal Executive Offices)   (Zip Code)

212-578-9500

(Registrant’s Telephone Number, Including Area Code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


Table of Contents

TABLE OF CONTENTS

 

Item 8.01 Other Events   
Item 9.01 Financial Statements and Exhibits   
SIGNATURES   
EXHIBIT INDEX   
EX-99.1   


Table of Contents

Item 8.01 Other Events.

On May 15, 2017, MetLife, Inc. issued a news release announcing the declaration of a quarterly dividend of $0.25555555 per share on MetLife, Inc.’s floating rate non-cumulative preferred stock, Series A, $25 liquidation preference per share, and a semi-annual dividend of $26.25 per share on MetLife, Inc.’s 5.250% fixed-to-floating rate non-cumulative preferred stock, Series C, $1,000 liquidation preference per share. A copy of the news release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(a) Not applicable.

(b) Not applicable.

(c) Not applicable.

(d) Exhibits

 

99.1    News release of MetLife, Inc., dated May 15, 2017, announcing the declaration of a quarterly dividend on its floating rate non-cumulative preferred stock, Series A, and a semi-annual dividend on its 5.250% fixed-to-floating rate non-cumulative preferred stock, Series C.


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

METLIFE, INC.
By:   /s/ Timothy J. Ring
  Name:   Timothy J. Ring
  Title:   Senior Vice President and Secretary

Date: May 15, 2017


Table of Contents

EXHIBIT INDEX

 

EXHIBIT
NUMBER

  

EXHIBIT

99.1    News release of MetLife, Inc., dated May 15, 2017, announcing the declaration of a quarterly dividend on its floating rate non-cumulative preferred stock, Series A, and a semi-annual dividend on its 5.250% fixed-to-floating rate non-cumulative preferred stock, Series C.
EX-99.1 2 d369445dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO

 

Contacts:    For Media:   

Jillian Palash

MetLife

(212) 578-1538

  
   For Investors:   

John Hall

MetLife

(212) 578-7888

  

MetLife Declares Second Quarter 2017 Preferred Stock Dividends

NEW YORK, May 15, 2017 – MetLife, Inc. (NYSE: MET) today announced that it has declared a quarterly dividend of $0.25555555 per share on the company’s floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE: METPrA). The company also declared a semi-annual dividend of $26.25 per share on the company’s 5.250% fixed-to-floating rate non-cumulative preferred stock, Series C, with a liquidation preference of $1,000 per share. Both dividends will be payable June 15, 2017, to shareholders of record as of May 31, 2017.

About MetLife

MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the largest life insurance companies in the world. Founded in 1868, MetLife is a global provider of life insurance, annuities, employee benefits and asset management. Serving approximately 100 million customers, MetLife has operations in nearly 50 countries and holds leading market positions in the United States, Japan, Latin America, Asia, Europe and the Middle East. For more information, visit www.metlife.com.

Forward-Looking Statements

This news release may contain or incorporate by reference information that includes or is based upon forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give expectations or forecasts of future events. These statements can be identified by the fact that they do not relate strictly to historical or current facts. They use words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe” and other words and terms of similar meaning, or are tied to future periods, in connection with a discussion of future operating or financial performance. In particular, these include statements relating to future actions, prospective services or products, future performance or results of current and anticipated services or products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, trends in operations and financial results.

Any or all forward-looking statements may turn out to be wrong. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. Many such factors will be important in determining the actual future results of MetLife, Inc., its subsidiaries and affiliates. These statements are based on current expectations and the current economic environment. They involve a number of risks and uncertainties that are difficult to predict. These statements are not guarantees of future performance. Actual results could differ materially from those expressed or implied in the forward-looking statements. Risks, uncertainties, and other factors that might cause such differences include the risks, uncertainties and other factors identified in MetLife, Inc.’s most recent Annual Report on Form 10-K (the “Annual Report”) filed with the U.S. Securities and Exchange Commission (the “SEC”), any Quarterly Reports on Form 10-Q filed by MetLife, Inc. with the SEC after the date of the Annual Report under the captions “Note Regarding Forward-Looking Statements” and “Risk Factors,” and other filings MetLife, Inc. makes


with the SEC. MetLife, Inc. does not undertake any obligation to publicly correct or update any forward-looking statement if MetLife, Inc. later becomes aware that such statement is not likely to be achieved. Please consult any further disclosures MetLife, Inc. makes on related subjects in reports to the SEC.

GRAPHIC 3 g369445g71b21.jpg GRAPHIC begin 644 g369445g71b21.jpg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end